PortViewPortView
Tyra Biosciences logo

Tyra Biosciences (TYRA) Stock Analysis

NASDAQHealthcareBiotechnology

$25.18-0.46%
1-year price historyRange $11.82 – $39.61
52-week range$25.18
$11.70$40.65

What Tyra Biosciences does

Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of programs addressing other critical conditions, including FGFR2-related intrahepatic cholangiocarcinoma, FGFR3-associated achondroplasia, REarranged during transfection (RET) kinase aberrations, and various FGFR4-driven cancers. Tyra also leverages its proprietary SNAP platform, designed to accelerate structural drug design through an iterative molecular 'snapshot' approach. Founded in 2018, Tyra Biosciences maintains its headquarters in Carlsbad, California.

Key metrics

Market cap
$1.50B
P/E (TTM)
-10.49
EPS (TTM)
$-2.40
Beta
0.77
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$29.30
200-day avg
$30.15
52-week high
$40.65
52-week low
$11.70
CEO
Todd Harris

ETFs linked to TYRA

Broad-market and Healthcare sector ETFs an investor holding Tyra Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TYRA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TYRA in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Tyra Biosciences?
Tyra Biosciences trades under the ticker TYRA on NASDAQ.
Which exchange is TYRA listed on?
TYRA is listed on NASDAQ.
What sector does Tyra Biosciences operate in?
Tyra Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TYRA in a portfolio?
PortView shows TYRA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.